Qiagen (QGEN): Sotuvning sof marjinal rentabelligi

Qiagen Corp (QGEN) korporativ emblemasi va logotipi

Thierry Bernard ishonch bilan Qiagen N.V. (QGEN) kompaniyasini testlarni avtomatlashtirish sohasida yetakchilikka olib bormoqda. Samarali boshqaruv, operatsion jihatdan toza savdo marjalaridan ko'rinib turganidek, talabning o'zgarishi sharoitida modelning barqarorligini ta'minladi. 18.20 qiymati ushbu ko'rsatkichning joriy holatini tavsiflaydi. Biznesning muvaffaqiyati zamonaviy laboratoriyalarda ish va shaxsiy hayot muvozanatini qadrlaydigan biologlardan iborat xalqaro xodimlarga bog'liq.

Qiagen N.V. (QGEN) - Sof marja 04.07.2022dan 20.11.2026gacha

Qiagen Corp (QGEN) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- bozor qiymati va tahlilchilarning maqsadli prognozi:
Kompaniyaning jamlanma tahlili:qiagen.com - QGEN
Qiagen Group yetakchi tovari

Qiagen N.V. (QGEN) diagnostikaga bo'lgan elastik bo'lmagan talab va yangi klinik ishlanmalarning muvaffaqiyati tufayli pasayish davrlarida foydani saqlab qolish qobiliyatini yo'qotmaydi. Sof foyda marjasini tahlil qilish orqali investor barcha xarajatlardan keyin daromadning qancha qismi sof foydaga aylanganini baholaydi, bu esa aktivning sifati va uning bozor tebranishlariga qarshi barqarorligining ob'ektiv ko'rsatkichi bo'lib xizmat qiladi.

Raqobatchilar tahlili

TEM: Sotuvning sof marjinal rentabelligi|Ionis (IONS) - Sotuvning sof marjinal rentabelligi|Sof marja Repligen|Avidity (RNA) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi CRSP|Kompaniya sotuv marjasi GeneDx|Sof marja Ultragenyx RARE|Kompaniya sotuv marjasi Beam Therapeutics (BEAM)|SRPT: Sof foyda bo'yicha sotuv rentabelligi|Sof marja Twist Bioscience|TXG (10x Genomics) - Sof foyda bo'yicha sotuv rentabelligi|Intellia Therapeutics, Inc. (NTLA) - Sotuvning sof marjinal rentabelligi|Sof marja Stoke Therapeutics Inc|BLFS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi WVE (Wave Life Sciences Corp)|Kompaniya sotuv marjasi Maze Therapeutics Corp|Sionna Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|PRME (primemedicine.com) - Sof foyda marjasi|TSHA - Sof marja|QURE (uniQure) - Sotuvning sof rentabelligi|MeiraGTx Corp (MGTX) - Sof marja|Regenxbio - Sof foyda normasi|Sof marja solidbio.com|Sof marja ocugen.com OCGN|Sotuvning sof marjinal rentabelligi PACB|Benitec - Sotuvning sof rentabelligi|Sof marja Design Therapeutics DSGN|Sotuvning sof marjinal rentabelligi Rocket Pharmaceuticals RCKT|Sof foyda marjasi 4D Molecular Corp|LXEO: Sof marja|KRRO (Korro Bio, Inc) - Sof foyda bo'yicha sotuv rentabelligi|Editas Medicine (EDIT) - Sotuvning sof marjinal rentabelligi|Sof marja Silence Therapeutics Inc.|Sotuvning sof rentabelligi PRQR (proqr.com)|Sof marja Codexis Bio (CDXS)|Sotuvning sof marjinal rentabelligi sangamo.com (SGMO)|Sof marja nautilus.bio NAUT|Kompaniya sotuv marjasi Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Sotuvning sof marjinal rentabelligi|GBIO - Sotuvning sof marjinal rentabelligi|BOLD: Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi XCUR|Sof marja Imunon|Phio Pharmaceuticals - Sof foyda marjasi|Sof marja Mustang Bio, Inc. (MBIO)|Kompaniya sotuv marjasi TransCode Therapeutics, Inc.|Sof marja Bionano Genomics BNGO|Sof foyda normasi APDN|BLUE - Sof marja|Sof foyda marjasi IPA|Omega Therapeutics, Inc. (OMGA) - Sof marja|Singular Genomics Corp (OMIC) - Sotuvning sof marjinal rentabelligi|RGLS (Regulus Therapeutics, Inc.) - Sotuvning sof marjinal rentabelligi|SYRS: Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi TBIO (Telesis Bio Inc.)|Sotuvning sof marjinal rentabelligi TRACON Pharmaceuticals Inc. (TCON)|Sof marja Unity Bio UBX